Champions Oncology, Inc. (CSBR) Social Stream

Champions Oncology, Inc. (CSBR): $7.98

0.01 (+0.13%)

POWR Rating

Component Grades













Add CSBR to Watchlist
Sign Up

Industry: Biotech


of 494

in industry

Champions Oncology Inc (CSBR) Price Targets From Analysts

Use the tables below to see what analysts covering Champions Oncology Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $16 $14 $15 $8.25 81.82%

Price Target Last Issued December 15, 2021

The Trend in the Analyst Price Target

CSBR's average price target has moved down $0.67 over the prior 144 days.

CSBR reports an average of 50.47% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-15 1 16 14.0 15.00 7.84 91.33%
2021-08-28 1 17 14.0 15.67 9.97 57.17%
2021-07-24 0 17 14.0 15.67 10.46 49.81%
2021-06-05 0 16 14.0 15.00 9.65 55.44%
2021-01-06 NA 14 13.5 13.83 11.16 23.92%

CSBR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The number of analysts covering the stock of CSBR is greater than nearly none of all US stocks.
  • CSBR has a lower variance in analysts' estimates than 87.6% of Pharmaceutical Products stocks.
  • The average analyst price target of CSBR is greater than 17.47% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of CSBR is higher than 77.34% of all US stocks.

Stocks similar to Champions Oncology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VLON, TARO and KMDA.

Is CSBR a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6504 seconds.